Among several different lethal tumours, the mortality of pancreatic cancer with poor efficiency after surgery is the highest. Late diagnosis and lack of symptoms contribute to pancreatic cancer's horrific mortality rate, and a growing body of research is trying to find a solution to the problem. With a deeper understanding and more research in signal pathways, many new target proteins come into sight. The downstream target of pancreatic cancer also become a significant hotspot for many researchers, in this review, it will analyze the main target in pancreatic cancer and try to illustrate the treatment by the target.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.